InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,558.89
(
-0.10%
)
US TECH 100
19,279.20
(
-0.13%
)
Dow Jones
40,383.31
(
-0.08%
)
Brent Oil
80.65
(
-1.06%
)
Bitcoin
65,629.93
(
-2.92%
)
Post# of 252652
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

biomaven0

Send PM Follow Ignore
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

biomaven0

Re: mcbio post# 219395

Tuesday, 06/05/2018 10:55:41 AM

Tuesday, June 05, 2018 10:55:41 AM

Post# of 252652
Their data is indeed good - better than TRIL's except for what TRIL has shown in CTCL. I was indeed surprised that they were able to overcome the antigen sink so well and increase dose so much.

Let's see what TRIL is able to do now that they too are increasing the dose more aggressively. We should get some data at ASH. I'll be particularly watching CTCL and PTCL.

Likely the FTSV IPO will be on the hot side.

Peter
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up